The PREDiCT: Tumour Models Summit  will return to London this December.

This 3-days summit is the definitive preclinical community for translational experts to assess updates on emerging models, compare human vs model systems and exchange ideas with key model developers. Through adopting the right preclinical platforms for your studies, you will be able to accelerate your immuno-oncology molecule into clinic,efficacy and minimising adverse effects for patients.  Join us in December and learn how to avoid trial-and-error and embrace new complex models which will subsequently empower your clinical decisions!